$10.50
-0.18[-1.69%]
At close: Apr 15
$10.50
0[0.00%]
After Hours: 5:48PM EDT
Amicus Therapeutics
(NASDAQ:FOLD)Amicus Therapeutics Stock (NASDAQ:FOLD), Quotes and News Summary
Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
| Open | $10.660 |
| Close | $10.660 |
| Volume / Avg. | 2.751M / 3.029M |
| Day Range | 10.590 - 10.810 |
| 52 Wk Range | 9.700 - 14.570 |
| Market Cap | $3.102B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 29 |
| Short Interest | 11.05% |
| Days to Cover | 13.81 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Amicus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amicus Therapeutics (FOLD) stock?
You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.
Who are Amicus Therapeutics's (FOLD) competitors?
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
What is the target price for Amicus Therapeutics (FOLD) stock?
The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by JP Morgan on Monday, March 18, 2024. The analyst firm set a price target for 19.00 expecting FOLD to rise to within 12 months (a possible 80.95% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Amicus Therapeutics (FOLD)?
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $10.5 last updated April 15, 2024 at 5:48 PM EDT.
Does Amicus Therapeutics (FOLD) pay a dividend?
There are no upcoming dividends for Amicus Therapeutics.
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is Amicus Therapeutics (FOLD) going to split?
There is no upcoming split for Amicus Therapeutics.
What sector and industry does Amicus Therapeutics (FOLD) operate in?
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.